This book deals with the complex dynamics of the health care sector, assessing, in particular, the risks inherent with an enforced regulation of an entire industry sector. The major focus is on value creation in general and biotechnology in particular. Since drugs constitute the bulk of biotechnological health care applications, and likewise both drug development and pricing is under particular governmental regulation, the book highlights the pharmaceutical sector whenever possible. Both practioners and policy makers will find the messages in this book helpful in creating value for their stakeholders.
Browse our Bookshelf Favorites store for big savings on popular fiction, nonfiction, children's books, and more. |
Book Description
Product Details
Would you like to update product info or give feedback on images? |
Customer Reviews
There are no customer reviews yet.
5 star
4 star
3 star
2 star
1 star
Share your thoughts with other customers
Sell a Digital Version of This Book in the Kindle Store
If you are a publisher or author and hold the digital rights to a book, you can sell a digital version of it in our Kindle Store.
Learn more
